Novo Nordisk (NVO.N): Filed a preliminary injunction motion in the U.S. District Court for the District of New Jersey, seeking an immediate halt to Eli Lilly's (LLY.N) misleading GLP-1 advertising campaign during the course of its litigation.
2026-07-24
Novo Nordisk (NVO.N): Filed a preliminary injunction motion in the U.S. District Court for the District of New Jersey, seeking an immediate halt to Eli Lilly's (LLY.N) misleading GLP-1 advertising campaign during the course of its litigation.